Related Experiment Video
Updated: Sep 29, 2025

04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.6K
Liposarcoma subtype recurrence and survival: A UK regional cohort study
Asif Machhada1, Ahmed Emam2, Guilia Colavitti2
1Department of Plastic Surgery, North Bristol NHS Trust, United Kingdom; Department of Surgery and Cancer, Imperial College London, United Kingdom.
Summary
Liposarcoma subtypes show distinct clinical outcomes. Atypical lipomatous tumors (ALT) have no metastases or disease-specific death, suggesting tailored surveillance is needed to reduce patient anxiety and unnecessary treatments.
Area of Science:
- Oncology
- Surgical Pathology
- Soft Tissue Tumors
Background:
- Liposarcoma is a common soft tissue sarcoma with varied histological subtypes.
- Current clinical outcome data lacks specificity for guiding surveillance of these subtypes.
- Histologic-specific differences in liposarcoma recurrence, progression, and survival are not well-defined.
Purpose of the Study:
- To demonstrate histologic-specific differences in liposarcoma recurrence, disease progression, and survival.
- To discuss the implications of these differences for surveillance protocols.
- To highlight the prognostic significance of liposarcoma subtypes.
Main Methods:
- A cohort study of 193 patients with primary liposarcoma excision from a UK regional sarcoma service (2002-2019).
- Liposarcoma subtypes classified according to WHO: atypical lipomatous tumors (ALT), myxoid, pleomorphic, and dedifferentiated.
- Outcomes (local recurrence, distant progression, disease-specific death) analyzed using Kaplan-Meier and Cox proportional hazard analyses.
Main Results:
- Significant differences (P < 0.0001) in recurrence, progression, and survival were observed across liposarcoma subtypes.
- Atypical lipomatous tumors (ALT) and their retroperitoneal variants showed no metastases or disease-specific death.
- Pulmonary metastases occurred in pleomorphic, dedifferentiated, and myxoid liposarcomas.
Conclusions:
- Atypical lipomatous tumors (ALT) exhibit a favorable prognosis with no observed metastases or disease-specific death.
- Surveillance protocols should differentiate between liposarcoma subtypes for more precise patient management.
- Tailored surveillance can reduce patient exposure to irradiation, time, fear, and anxiety.

